|
Johnson & Johnson (J&J), a global leader in eye health, has announced it’s expanding the roll-out of its latest advancement in presbyopia-correcting intraocular lenses (PC - IOL), TECNIS Odyssey, in the US. The new full visual range IOL offers patients unmatched continuous full range of vision, so they can see clearly from far to near and in between, minimizing their need for glasses.
TECNIS Odyssey IOL is built on the TECNIS platform, providing two-times better contrast in low lighting than PanOptix. In addition, TECNIS Odyssey IOL patients are able to read 14% smaller print on average than PanOptix IOL patients and 93% reported no or mild halos, glare, or starbursts one month after surgery.
“More than 14,000 eyes have already benefited from TECNIS Odyssey, our new full visual range IOL. TECNIS Odyssey patients have reported outstanding visual outcomes following surgery, which is why we are excited to announce we are expanding the roll-out across the US today,” said Peter Menziuso, company group chairman, Vision, Johnson & Johnson. “Cataract surgery gives patients a once in a lifetime opportunity to improve their sight, and now with this advanced IOL, patients can see clearly at every distance, without the need for glasses.”
It is estimated that 20.5 million (17.2%) Americans aged 40 years and older have a cataract in one or both eyes, yet only 6.1 million (5.1%) have had cataract surgery. Left untreated, cataracts cause vision to deteriorate over time. Many people who have cataracts experience other problems with their vision, such as presbyopia, which is a progressive eye condition that makes it difficult to focus on close objects and usually becomes noticeable around 40 years of age. Full visual range IOLs provide the opportunity to correct presbyopia at the time of cataract surgery.
“The TECNIS Odyssey IOL is perhaps the most comprehensive and well-balanced PC-IOL on the market to date,” said Dr. George O. Waring IV, medical director of the Waring Vision Institute in Mt. Pleasant, SC. “It falls under a new standard of full vision range that provides extraordinary contrast in both day and night-time conditions, tolerance to refractive error and minimal dysphotopsias with outstanding contrast sensitivity that really takes it to a whole different level and nothing like we’ve seen before with prior PC-IOLs”.
The new TECNIS Odyssey full visual range IOL was built with proprietary technology that results in superior image quality, delivering sharp vision even in challenging lighting conditions. The design also delivers fewer visual disturbances for enhanced night-time visual quality:
· Precise vision: TECNIS Odyssey IOL ensures crisp and clear vision, allowing patients to see with clarity at every distance - whether they are reading, driving or engaging in daily activities.
94% of patients were satisfied with their overall vision without glasses3
At every distance: Its unique, freeform diffractive surface was designed to eliminate the gaps between near, intermediate and far distances, and offer continuous, uninterrupted vision at all distances.
96% of patients were satisfied with reading a smartphone or tablet, and 97% were satisfied with distance vision.
In any lighting: Engineered to minimize night vision disturbances – fewer halos and glare.
TECNIS Odyssey IOL provides better image quality than PanOptix day and night, for a more comfortable night-time experience.
92% of patients were satisfied with their ability to see steps at nightand read street signs at night.
As part of this roll-out, J&J is launching “TECNIS Odyssey IOL Peer Connect”. This initiative was designed to foster direct and meaningful medical and scientific conversations regarding TECNIS Odyssey IOL between healthcare professionals with expert surgeons who had early access to the technology.
TECNIS Odyssey IOL has also received regulatory authority approval in Japan, EU, Korea, Canada, Singapore, Australia and New Zealand.
Johnson & Johnson has a deep legacy in developing transformational new products that improve the health of patients’ eyes. As a global leader in eye-health, we have a bold ambition: Vision Made Possible – and are paving the way for a new future of eye health to support the full spectrum of paediatric, developed and mature eyes.
|